Health
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal
CEO Albert Bourla says company will use gene-based technology learned by working with Germany’s BioNTech to tackle other diseases
Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoFirst home buyers score early access to deposit scheme